Safety and Efficacy of Polatuzumab Vedotin + Obinutuzumab for Relapsed/Refractory NHL: A Phase 1b/2 Study
暂无分享,去创建一个
I. Flinn | D. Ramies | T. Phillips | F. Morschhauser | J. Essell | C. Diefenbach | A. Chiappella | J. Hirata | M. Brunvand | Ji Cheng | A. Chen